Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

AB Science stops phase III study of masitinib in rheumatoid arthritis

Sep. 23, 2015

Rat forelimb allotransplantation model enables assessment of function

Sep. 22, 2015

Corbus initiates phase II trial of Resunab for systemic sclerosis

Sep. 3, 2015

FDA approves Augment Bone Graft

Sep. 2, 2015

Promising topline results from phase III STRUCTURE trial of romosozumab

Sep. 2, 2015

FDA grants fast track designation to Flexion's FX-006 for knee osteoarthritis pain

Sep. 2, 2015

Asahi Kasei announces launch date for Xiaflex in Japan

Sep. 1, 2015

Seikagaku terminates license agreement with Can-Fite BioPharma for RA product

Sep. 1, 2015

Audentes Therapeutics' AT-001 receives orphan drug designation

Aug. 27, 2015

Tracleer approved in Japan for new digital ulcers in patients with systemic scleroderma

Aug. 26, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...